Livalo is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Kowa Pharmaceuticals America, Inc.. The primary component is Pitavastatin Calcium.
Product ID | 66869-404_1783ecd3-0116-4ad8-9a43-25d5b2dc62e6 |
NDC | 66869-404 |
Product Type | Human Prescription Drug |
Proprietary Name | Livalo |
Generic Name | Pitavastatin Calcium |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2019-05-16 |
Marketing Category | NDA / NDA |
Application Number | NDA022363 |
Labeler Name | Kowa Pharmaceuticals America, Inc. |
Substance Name | PITAVASTATIN CALCIUM |
Active Ingredient Strength | 4 mg/1 |
Pharm Classes | HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2019-05-16 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022363 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-05-16 |
Marketing Category | NDA |
Application Number | NDA022363 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-05-16 |
Ingredient | Strength |
---|---|
PITAVASTATIN CALCIUM | 4.18 mg/1 |
SPL SET ID: | 44dcbf97-99ec-427c-ba50-207e0069d6d2 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
66869-104 | Livalo | pitavastatin calcium |
66869-204 | Livalo | pitavastatin calcium |
66869-404 | Livalo | pitavastatin calcium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LIVALO 79016899 3228048 Live/Registered |
KOWA COMPANY, LTD. 2005-08-26 |
LIVALO 76600233 2993941 Dead/Cancelled |
Livalo Design Inc. 2004-07-01 |
LIVALO 76147782 not registered Dead/Abandoned |
Livalo Design Inc. 2000-10-16 |